<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/123456789/81">
    <title>Ain Shams Scholar Collection:</title>
    <link>http://hdl.handle.net/123456789/81</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/220902" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/220716" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/220715" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/220714" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-09T21:59:46Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/123456789/220902">
    <title>COVID-19 vaccines research</title>
    <link>http://hdl.handle.net/123456789/220902</link>
    <description>Title: COVID-19 vaccines research
Authors: Adel, Sajad</description>
    <dc:date>2026-03-05T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/220716">
    <title>Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancer</title>
    <link>http://hdl.handle.net/123456789/220716</link>
    <description>Title: Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancer
Authors: Elghazawy, Hagar; Bakkach, Joaira; Helal, Thanaa; Aref, Ahmed M; kelany, mohamed; Abdallah, Lamiaa E; Abdelbakey, Fatma S; Aly, Dalia; Ali, Doaa Z; Ahmed, Mai O; El-Hafeez, Amer Ali Abd; Ghosh, Pradipta; Alorabi, Mohamed
Abstract: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) with ill-defined therapeutic targets. Androgen receptor (AR) and tumour-infiltrating lymphocytes (TILs) had a prognostic and predictive value in TNBC. The relationship between AR, TILs and clinical behaviour is still not fully understood.</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/220715">
    <title>Predictors of poor precautionary practices towards COVID-19 among cancer patients</title>
    <link>http://hdl.handle.net/123456789/220715</link>
    <description>Title: Predictors of poor precautionary practices towards COVID-19 among cancer patients
Authors: Jazieh, Abdul R; Bensalem, Assia A; Bounedjar, Adda; Benbrahim, Zineb; Abusanad, Atlal M; Tashkandi, Emad M; Alnassar, Muath Ama; El Kinge, Abdul Rad; Al-Sukhun, Sana; Alsharm, Abdullah; Errihani, Hassan; Abdelhafiez, Nafisa A; Alkaiyat, Mohammad; Jradi, Hoda; Alorabi, Mohamed
Abstract: Objective: Our study goal was to evaluate the behavioral response and practices of cancer patients to the coronavirus disease 2019 (COVID-19) pandemic in the Middle East and north Africa. Methods: A cross-sectional study was conducted using a validated anonymous 45-question survey administered via SurveyMonkey® to cancer patients in 13 centers in Algeria, Egypt, Jordan, Kuwait, Morocco and Saudi Arabia. Results: During the study period (from 21 April to 30 May 2020), 3642 patients participated in the study. The majority of patients (84.81%) were worried about contracting the infection. The reported strict adherence to precautions included avoiding the following actions: hand-shaking (77.40%), hugging and kissing (82.89%), social gathering (90.09%), meeting friends (84.68%) and visiting markets (75.65%). In a multivariate analysis, patients with poor precautionary practices were about twice as likely to cancel their medical appointment or a treatment session. Conclusion: Improving cancer patients' knowledge of and adherence to precautionary measures is needed not just to reduce the risk of acquiring infection but also to minimize the interruption of their medical care.</description>
    <dc:date>2021-12-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/220714">
    <title>Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancer</title>
    <link>http://hdl.handle.net/123456789/220714</link>
    <description>Title: Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancer
Authors: Alorabi, Mohamed Osama; Gouda, Abdelrahman; Yassmen Said Ahmed; Abdelaal, Moamen; Eid, Reem; Yahia, Maha; Alorabi, Mohamed
Abstract: The role of adjuvant chemotherapy in rectal cancer patients downstaged to ypT0-2 N0 after neoadjuvant chemoradiotherapy (CRT), and surgery is still debated. This study investigates the impact of adjuvant chemotherapy on survival outcomes in this patient population.</description>
    <dc:date>2025-01-03T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

